OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway.
Wei H, Li W, Zeng L, Ding N, Li K, Yu H, Jiang F, Yin H, Xia Y, Deng C, Cai N, Chen X, Gu L, Chen H, Zhang F, He Y, Li J, Zhang C.
Wei H, et al. Among authors: yin h.
Mol Cancer. 2024 Jun 7;23(1):124. doi: 10.1186/s12943-024-02016-9.
Mol Cancer. 2024.
PMID: 38849840
Free PMC article.